LivaNova Company Profile

23:09 EDT 20th March 2018 | BioPortfolio

News Articles [50 Associated News Articles listed on BioPortfolio]

LivaNova buys TandemLife

To expand its cardiac surgery portfolio, LivaNova PLC is paying $200mm to acquire private cardiopulmonary device maker TandemLife (formerly known as CardiacAssist). LivaNova could also hand over up to...

Trial begins for LivaNova's depression treatment system

The first patient in a postmarket study of LivaNova's VNS therapy system was enrolled at Universitatsklinikum Jena in Germany -More- 

LivaNova enters $250M deal to acquire TandemLife

LivaNova agreed to pay $200 million upfront plus up to $50 million in contingent payments based on regulatory milestones for  -More- 

Study begins for LivaNova's bioprosthetic aortic heart valves

A prospective postmarket study was initiated by LivaNova to identify the overall incidence of reduced leaflet motion detected -More- 

LivaNova to pay up to $225mm for ImThera

LivaNova PLC is buying closely held sleep apnea device maker ImThera Medical Inc. for $78mm up front and up to $147mm in potential regulatory and sales milestones.

LivaNova reaches $225M deal to buy ImThera Medical

LivaNova agreed to pay $78 million upfront plus $147 million based on regulatory and sales milestones for investee ImThera Me -More- 

LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2017 Results

LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, will host a conference call to discuss its fourth quarter and full-y...

LivaNova to Present at the Piper Jaffray and Berenberg Conferences

LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, and Thad H...

Drugs and Medications [0 Results]


PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Long-term outcomes using the stentless LivaNova-Sorin Pericarbon Freedom™ valve after aortic valve replacement.

Information on the long-term safety, efficacy and durability of third-generation stentless aortic valves is lacking.

Aortic Valve Replacement With Perceval Bioprosthesis: Single-Center Experience With 617 Implants.

This study describes the clinical and echocardiographic outcomes in a large single-center cohort of patients who underwent aortic valve replacement (AVR) with a sutureless Perceval (LivaNova, Milan, I...

Sutureless Perceval Aortic Valve Versus Conventional Stented Bioprostheses: Meta-Analysis of Postoperative and Midterm Results in Isolated Aortic Valve Replacement.

Aortic stenosis is the most common valvular disease and has a dismal prognosis without surgical treatment. The aim of this meta-analysis was to quantitatively assess the comparative effectiveness of t...

Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.

Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (LivaNova PLC, London, UK) compared to the Carpentier ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Behavior of Valve Leaflets

This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a commercially approved L...

Companies [3 Associated Companies listed on BioPortfolio]

LivaNova, PLC

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Li...

LivaNova PLC

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...


More Information about "LivaNova" on BioPortfolio

We have published hundreds of LivaNova news stories on BioPortfolio along with dozens of LivaNova Clinical Trials and PubMed Articles about LivaNova for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LivaNova Companies in our database. You can also find out about relevant LivaNova Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record